Call for more research and greater efforts to prevent and control the spread of herpes simplex virus
21 January 2015 - New WHO-led global estimates for herpes simplex virus type 2, published by PLOS ONE, show that over 400 million people worldwide were infected with the virus in 2012. The estimates underline the extent to which herpes simplex virus type 2 – the virus which causes genital herpes – is widespread throughout the world, causing a significant global burden of disease.
Screening for syphilis accurately requires quality laboratory services. The WHO/CDC Syphilis Serology Proficiency Programme (WHO/CDC SLPP) was established several years ago in order to assess the performance and reliability of laboratory testing, in particular for low- and middle-income countries.
Sexually transmitted infections are a massive health challenge with more than a million new infections occurring every day. Increased investment in research and development for new vaccines is key to halting the spread of genital herpes, gonorrhoea, chlamydia, syphilis, and trichomoniasis, according to a new special issue of the journal Vaccine, co-edited by WHO and the United States’ National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH).
Investing in screening and treatment for syphilis in pregnant women ranks as one of the most cost-effective antenatal interventions. Screening all pregnant women, using simple and low-cost technologies, is feasible, even in low-resource settings. Syphilis is easily cured with penicillin, and MTCT of syphilis is easily prevented when pregnant mothers with syphilis infection are identified early and treated promptly.